Precision Biosensor, Inc. (KOSDAQ:335810)
South Korea · Delayed Price · Currency is KRW 2,235.00
-75.00 (-3.25%)
At close: Apr 2, 2026
Precision Biosensor Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 19,926 | 19,134 | 20,391 | 20,458 | 15,887 |
Other Revenue | - | -0 | - | - | -0 |
| 19,926 | 19,134 | 20,391 | 20,458 | 15,887 | |
Revenue Growth (YoY) | 4.14% | -6.17% | -0.33% | 28.77% | 82.93% |
Cost of Revenue | 13,506 | 12,952 | 12,705 | 13,703 | 11,282 |
Gross Profit | 6,420 | 6,182 | 7,686 | 6,755 | 4,605 |
Selling, General & Admin | 7,509 | 6,406 | 7,288 | 7,437 | 6,303 |
Research & Development | 2,584 | 3,586 | 3,196 | 2,611 | 1,958 |
Amortization of Goodwill & Intangibles | 548.63 | 548.63 | 547.69 | 50.22 | 1.85 |
Other Operating Expenses | 333.18 | 363.88 | 249.05 | 231.68 | 243.58 |
Operating Expenses | 11,801 | 11,549 | 12,496 | 11,255 | 8,874 |
Operating Income | -5,381 | -5,366 | -4,811 | -4,500 | -4,269 |
Interest Expense | -2,097 | -1,991 | -1,230 | -816.95 | -162.1 |
Interest & Investment Income | 86.65 | 164.95 | 188.19 | 187.26 | 70.52 |
Currency Exchange Gain (Loss) | -98.65 | 577.46 | 196.85 | 254.17 | 285.95 |
Other Non Operating Income (Expenses) | 34.26 | -709.87 | -172.23 | -2,273 | -254.15 |
EBT Excluding Unusual Items | -7,456 | -7,324 | -5,827 | -7,148 | -4,329 |
Gain (Loss) on Sale of Investments | 2.42 | 33.36 | 90.06 | 137.79 | 48.66 |
Gain (Loss) on Sale of Assets | -16.05 | 3.01 | - | 5.27 | 0.03 |
Asset Writedown | -1,981 | - | - | - | - |
Other Unusual Items | -552.96 | 319.15 | 354.95 | - | - |
Pretax Income | -10,004 | -6,969 | -5,382 | -7,005 | -4,281 |
Income Tax Expense | 19.18 | 336.5 | -892.03 | -199.36 | -128.31 |
Net Income | -10,023 | -7,305 | -4,490 | -6,806 | -4,152 |
Net Income to Common | -10,023 | -7,305 | -4,490 | -6,806 | -4,152 |
Shares Outstanding (Basic) | 13 | 12 | 12 | 12 | 11 |
Shares Outstanding (Diluted) | 13 | 12 | 12 | 12 | 11 |
Shares Change (YoY) | 8.69% | 0.09% | 0.67% | 2.10% | 25.37% |
EPS (Basic) | -794.00 | -629.00 | -386.98 | -590.47 | -367.80 |
EPS (Diluted) | -794.00 | -629.00 | -387.00 | -590.47 | -368.00 |
Free Cash Flow | -1,670 | -1,509 | -9,006 | -13,719 | -13,726 |
Free Cash Flow Per Share | -132.31 | -129.93 | -776.13 | -1190.18 | -1215.81 |
Gross Margin | 32.22% | 32.31% | 37.69% | 33.02% | 28.98% |
Operating Margin | -27.01% | -28.04% | -23.59% | -22.00% | -26.87% |
Profit Margin | -50.30% | -38.18% | -22.02% | -33.27% | -26.14% |
Free Cash Flow Margin | -8.38% | -7.89% | -44.17% | -67.06% | -86.40% |
EBITDA | -1,424 | -1,777 | -1,665 | -2,218 | -3,091 |
EBITDA Margin | -7.15% | -9.29% | -8.17% | -10.84% | -19.45% |
D&A For EBITDA | 3,957 | 3,590 | 3,145 | 2,282 | 1,179 |
EBIT | -5,381 | -5,366 | -4,811 | -4,500 | -4,269 |
EBIT Margin | -27.01% | -28.04% | -23.59% | -22.00% | -26.87% |
Advertising Expenses | 120.15 | 114.04 | 200 | 76.59 | 108.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.